摘要
Oxaliplatin is a widely applied anti-cancer drug in clinics for colorectal cancer (CRC) treatment. Nonetheless, the treatment efficacy is always limited by the acquisition of chemoresistance in cancer cells. The deregulation of long non-coding RNA (lncRNA) FAL1 has been implicated in the tumorigenesis and progression of different malignancies. Nevertheless, the possible contribution of lnc-FAL1 in drug resistance development of CRC has not been investigated. Here, we reported the overexpression of lnc-FAL1 in CRC samples, and elevated lnc-FAL1 levels seemed to be associated with the poor survival in CRC patients. We further demonstrated that lnc-FAL1 promoted oxaliplatin chemoresistance in both cell and animal model. Additionally, lnc-FAL1 was mainly derived from exosomes secreted by cancer associated fibroblasts (CAFs), and lnc-FAL1-containing exosomes or lnc-FAL1 overexpression significantly inhibited oxaliplatin-induced autophagy in CRC cells. Mechanistically, lnc-FAL1 acted as a scaffold for the interaction between Beclin1 and TRIM3 to promote TRIM3-dependent Beclin1 polyubiquitination and degradation, thereby suppressing oxaliplatin-induced autophagic cell death. In summary, these data imply a molecular mechanism through which CAF-derived exosomal lnc-FAL1 contributes to the acquisition of oxaliplatin resistance in CRC.
学科与关键词
- A Novel Protein Encoded by Exosomal CircATG4B Induces Oxaliplatin Resistance in Colorectal Cancer by Promoting AutophagyPan, Zihao; Zheng, Jun; Zhang, Jiebin; Lin, Jiatong; Lai, Jianguo; Lyu, Zejian; Feng, Huolun; Wang, Junjiang*; Wu, Deqing*; Li, Yong*Advanced Science, 2022, 9(35).被引 26
- Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancerHashemi, Mehrdad; Esbati, Nastaran; Rashidi, Mohsen; Gholami, Sadaf; Raesi, Rasoul; Bidoki, Seyed Shahabadin; Goharrizi, Mohammad Ali Sheikh Beig; Motlagh, Yasamin Sadat Mousavi; Khorrami, Ramin; Tavakolpournegari, Alireza; Nabavi, Noushin; Zou, Rongjun; Mohammadnahal, Leila*; Entezari, Maliheh*; Taheriazam, Afshin*; Hushmandi, Kiavash*Translational Oncology, 2024, 40: 101846.
- LncRNA CACClnc promotes chemoresistance of colorectal cancer by modulating alternative splicing of RAD51Zhang, Xinyu; Ma, Dan; Xuan, Baoqin; Shi, Debing; He, Jie; Yu, Minhao; Xiong, Hua; Ma, Yanru; Shen, Chaoqin; Guo, Fangfang; Cao, Yingying; Yan, Yuqing; Gao, Ziyun; Tong, Tianying; Zhu, Xiaoqiang; Fang, Jing-Yuan; Chen, Haoyan*; Hong, Jie*Oncogene, 2023, 42(17): 1374-1391.被引 4
